Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-01-22

Clinical Trial Update: to Evaluate the Effectiveness and Safety of the Tixel® , VS LipiFlow® in the Treatment of Meibomian Gland Dysfunction [NA]

View source ↗

Summary

A completed trial comparing Tixel and LipiFlow for Meibomian Gland Dysfunction has posted results. The study assessed effectiveness and safety for Meibomian Gla…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LipiFlow
  • Tixel

Snippet

Sponsor: Novoxel Ltd. | Conditions: Meibomian Gland Dysfunction, Dry Eye Syndromes | NA | Status: COMPLETED | Results posted: 2025-01-22